Page last updated: 2024-11-08

oxazolidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

oxazolidine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID536683
CHEMBL ID4297314
CHEBI ID50310
MeSH IDM0176951

Synonyms (22)

Synonym
13f52uf6mr ,
unii-13f52uf6mr
bioban cs-1246
epa pesticide chemical code 128909
504-76-7
1,3-oxazolidine
CHEBI:50310
oxazolidine
AKOS006351677
FT-0673338
1,3-oxazolidine #
DTXSID50198446
A51210
Q417695
AMY42397
CHEMBL4297314
A903220
CS-0214988
EN300-211422
mfcd16251479
SY060692
1,3-oxazolidine, tech grade

Research Excerpts

Treatment

ExcerptReferenceRelevance
"The oxazolidine treated leathers were found to be immensely fuller and tighter."( Enhancement of chromium uptake in tanning using oxazolidine.
Brutto, PE; Mandal, AB; Ramanaiah, B; Ramesh, R; Saravanan, P; Siddhartha, G; Sundarapandiyan, S, 2011
)
1.11

Bioavailability

ExcerptReferenceRelevance
" Despite the potential for hydrolytic instability at gut pH, compounds of the present class showed good oral bioavailability and were highly active in a standard rodent pharmacological model."( N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientation.
An, Y; Beehler, BC; Bryson, JA; DiMarco, J; Egan, D; Fura, A; Golla, R; Gougoutas, JZ; Grover, GJ; Hamann, LG; Kish, KF; Krystek, SR; Kuhns, JE; Li, YX; Lupisella, JA; Nirschl, AA; Ostrowski, J; Sack, JS; Seethala, R; Simpkins, LM; Sleph, PG; Sutton, JC; Vyas, VP; Zahler, R; Zou, Y, 2009
)
0.35

Dosage Studied

ExcerptRelevanceReference
"01) and dose-response pattern of the cytokines IL-6, IL-17A, IL-22, and IL-10."( Investigation of a new oxazolidine derivative in human resistance acute leukemia cells: deciphering its mechanism of action by label-free proteomic.
Abdelhay, E; da Rocha Pitta, I; da Rocha Pitta, MG; de Melo RĂªgo, MJB; de Sena, WLB; do Carmo Alves de Lima, M; do Nascimento Carvalho, LV; Pereira, MC; Pizzatti, L; Souza, GHMF, 2021
)
0.93
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
oxazolidine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (201)

TimeframeStudies, This Drug (%)All Drugs %
pre-199029 (14.43)18.7374
1990's7 (3.48)18.2507
2000's65 (32.34)29.6817
2010's79 (39.30)24.3611
2020's21 (10.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.64 (24.57)
Research Supply Index5.35 (2.92)
Research Growth Index5.38 (4.65)
Search Engine Demand Index66.20 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (44.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (2.87%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other203 (97.13%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]